Capivasertib

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Capivasertib
Treatment and conditionWhere it standsTrials
Capivasertib for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Capivasertib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Capivasertib for neoplasm metastasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Capivasertib for prostatic neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Capivasertib for uterine cervical neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1